Kelgan Pharmaceutical Private Limited
About Kelgan Pharmaceutical Private Limited
Data last updated:
Kelgan Pharmaceutical Private Limited is a private limited company based in Kota, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33309RJ2016PTC056331. Its GSTIN is 08AAGCK3500J1ZO (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kewal Prakash Sharma and Lokesh Gautam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 13 Chitresh Nagar Vistar Borkhera, Kota, Rajasthan, India – 324001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.16 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Lakh (net margin 0.9%) and EBITDA of ₹1.71 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – 13 Chitresh Nagar Vistar Borkhera, Kota, Rajasthan, India – 324001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kelgan Pharmaceutical Private Limited
The main business activity of Kelgan Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kelgan Pharmaceutical Private Limited FY 2025 filings available
Kelgan Pharmaceutical Private Limited reported revenue of ₹1.16 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kelgan Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 7% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kelgan Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.71 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.09 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kelgan Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kelgan Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kewal Prakash Sharma | Director | 07 Nov 2016 | 9 Years 11 Months | Current |
| Lokesh Gautam | Director | 07 Nov 2016 | 9 Years 11 Months | Current |
Peer Comparison of Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arunshanti Enterprises Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | -60.0% | •••• | Chennai, Tamil Nadu, India |
| Minetrack Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Kolkata, West Bengal, India |
| Asprant Life Science Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Kolkata, West Bengal, India |
| JS Agro Foods Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Chennai, Tamil Nadu, India |
| STC Marble House Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | 159.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Kelgan Pharmaceutical Private Limited this company | ₹1.16 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Kota, Rajasthan, India |
| Sri Padmavathi Expotrade Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | 166.0% | •••• | Secunderabad, Telangana, India |
| Thamizh Industries Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | 228.0% | •••• | Tirunelveli, Tamil Nadu, India |
| Swarnim Exports Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Patna, Bihar, India |
| RSP Overseas Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | 129.0% | •••• | Kolkata, West Bengal, India |
| Eynk Retails Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Kelgan Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Kelgan Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kelgan Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Kelgan Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Kewal Prakash Sharma was appointed as Director on 07 Nov 2016.
Credit Ratings, Litigation & Regulatory Alerts for Kelgan Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kelgan Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kelgan Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCK3500J1ZO | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kelgan Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kelgan Pharmaceutical Private Limited
Kelgan Pharmaceutical is an active private limited company based in Kota, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 November 2016 (10+ years old) and is registered under CIN U33309RJ2016PTC056331.
Kelgan Pharmaceutical reported revenue of ₹1.16 Cr for FY 2025 (up 7% YoY).
Kelgan Pharmaceutical has 2 current directors:
- Kewal Prakash Sharma - Director
- Lokesh Gautam - Director
Kelgan Pharmaceutical reported a net profit of ₹1.09 Lakh (net margin 0.9%) and EBITDA of ₹1.71 Lakh (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kelgan Pharmaceutical is 21% over three years and 22% over five years. In the latest year (FY 2025) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kelgan Pharmaceutical is 08AAGCK3500J1ZO, registered in Rajasthan.
The CIN (Corporate Identification Number) of Kelgan Pharmaceutical is U33309RJ2016PTC056331. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kelgan Pharmaceutical was incorporated on 07 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Kelgan Pharmaceutical by revenue are Arunshanti Enterprises Private Limited, Minetrack Private Limited, Asprant Life Science Private Limited, JS Agro Foods Private Limited, STC Marble House Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Kewal Prakash Sharma was appointed as Director on 07 Nov 2016. Lokesh Gautam was appointed as Director on 07 Nov 2016.
The registered office of Kelgan Pharmaceutical is at E – 13 Chitresh Nagar Vistar Borkhera, Kota, Rajasthan, India – 324001.